3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs
- PMID: 1246007
3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs
Abstract
Tolerant and nontolerant dogs received one i.v. administration of 0.5 mg/kg of 3H-delta9-tetrahydrocannabinol 30 minutes before they were sacrificed. Plasma, peripheral and brain tissues, as well as subcellular fractions of brain tissues from both treatment groups, were analyzed for radioactivity. Throughout the time period before sacrifice, the plasma concentrations of radioactivity in the tolerant and nontolerant dogs were not significantly different. The percentage of radioactivity in brain and plasma that was due to either unchanged delta9-tetrahydrocannabinol or a major metabolite was the same in each group. Of the radioactivity in brain, 46% was identified as delta9-tetrahydrocannabinol. Regardless of treatment, there was a specific accumulation of radioactivity in adrenals, liver, kidney, heart and pancreas. The only significant differences in radioactivity between tolerant and nontolerant peripheral tissues were found in liver, kidney cortex, heart and lymph nodes. Although all brain areas from tolerant dogs contained less radioactivity than the comparable brain areas from nontolerant animals, only pituitary and putamen were significantly less. There was a specific accumulation of radioactivity in some brain areas that could be associated with behavioral effects. The concentration in cerebellar and cerebral gray was significantly greater than that in white, and there was a marked reduction in the concentration in gray after tolerance developed. The mean percentage of radioactivity in each subcellular fraction was as follows: 23% crude nuclei, 44% mitochondria, 8% cholinergic nerve endings, 7% noncholinergic nerve endings, 2% free mitochondria and 6% synaptic vesicles. The quantity of radioactivity in homogenates of brains from tolerant dogs was 17% less than brains of nontolerant animals, which was merely a reflection of the respective plasma concentrations. The distribution of radioactivity was similar in both groups, although most of the subcellular fractions from tolerant dogs contained a lesser amount of radioactivity. The most notable difference was observed in the synaptic vesicle fraction. The synaptic vesicle fraction of tolerant dogs contained 40% less radioactivity than did the same fraction from nontolerant dogs, which implied a possible mechanism of action. A comparison of the remaining subcellular fractions did not appear to explain the development of tolerance.
Similar articles
-
3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses.Res Commun Chem Pathol Pharmacol. 1977 Jul;17(3):457-70. Res Commun Chem Pathol Pharmacol. 1977. PMID: 897339
-
Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin.Drug Metab Dispos. 1978 May-Jun;6(3):282-7. Drug Metab Dispos. 1978. PMID: 26549
-
An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.Pol J Pharmacol Pharm. 1976 Nov-Dec;28(6):589-92. Pol J Pharmacol Pharm. 1976. PMID: 1012982
-
Intracellular distribution of 3h-delta8-tetrahydrocannabinol in rat organs after I.V. administration.Res Commun Chem Pathol Pharmacol. 1974 Sep;9(1):197-200. Res Commun Chem Pathol Pharmacol. 1974. PMID: 4438825 No abstract available.
-
Toxicological and pharmacological effects.NIDA Res Monogr. 1977 Jul;(14):67-85. NIDA Res Monogr. 1977. PMID: 199843 Review. No abstract available.
Cited by
-
Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats.Psychopharmacology (Berl). 1977 Jan 31;51(2):141-5. doi: 10.1007/BF00431730. Psychopharmacology (Berl). 1977. PMID: 402665
-
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.J Pharmacol Exp Ther. 2013 Jun;345(3):492-501. doi: 10.1124/jpet.112.201426. Epub 2013 Feb 14. J Pharmacol Exp Ther. 2013. PMID: 23412396 Free PMC article.
-
Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure.Drug Alcohol Depend. 2014 Jun 1;139:1-8. doi: 10.1016/j.drugalcdep.2014.02.696. Epub 2014 Mar 19. Drug Alcohol Depend. 2014. PMID: 24703610 Free PMC article.
-
The Endocannabinoid System of Animals.Animals (Basel). 2019 Sep 16;9(9):686. doi: 10.3390/ani9090686. Animals (Basel). 2019. PMID: 31527410 Free PMC article. Review.
-
Histamine release in dogs by Emulphor EL620.Experientia. 1979 Mar 15;35(3):338-9. doi: 10.1007/BF01964338. Experientia. 1979. PMID: 87339